1. Home
  2. KLXE vs CTMX Comparison

KLXE vs CTMX Comparison

Compare KLXE & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • CTMX
  • Stock Information
  • Founded
  • KLXE 2018
  • CTMX 2008
  • Country
  • KLXE United States
  • CTMX United States
  • Employees
  • KLXE N/A
  • CTMX N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • CTMX Health Care
  • Exchange
  • KLXE Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • KLXE 35.8M
  • CTMX 444.3M
  • IPO Year
  • KLXE N/A
  • CTMX 2015
  • Fundamental
  • Price
  • KLXE $1.95
  • CTMX $2.41
  • Analyst Decision
  • KLXE Hold
  • CTMX Strong Buy
  • Analyst Count
  • KLXE 1
  • CTMX 2
  • Target Price
  • KLXE $4.50
  • CTMX $5.00
  • AVG Volume (30 Days)
  • KLXE 295.3K
  • CTMX 2.6M
  • Earning Date
  • KLXE 08-06-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • KLXE N/A
  • CTMX N/A
  • EPS Growth
  • KLXE N/A
  • CTMX 128.27
  • EPS
  • KLXE N/A
  • CTMX 0.49
  • Revenue
  • KLXE $688,600,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • KLXE N/A
  • CTMX N/A
  • Revenue Next Year
  • KLXE $3.97
  • CTMX N/A
  • P/E Ratio
  • KLXE N/A
  • CTMX $5.15
  • Revenue Growth
  • KLXE N/A
  • CTMX 23.81
  • 52 Week Low
  • KLXE $1.51
  • CTMX $0.40
  • 52 Week High
  • KLXE $7.66
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 45.50
  • CTMX 57.13
  • Support Level
  • KLXE $1.84
  • CTMX $2.15
  • Resistance Level
  • KLXE $2.06
  • CTMX $2.44
  • Average True Range (ATR)
  • KLXE 0.29
  • CTMX 0.22
  • MACD
  • KLXE -0.04
  • CTMX -0.03
  • Stochastic Oscillator
  • KLXE 9.48
  • CTMX 41.67

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: